SAB Biotherapeutics Inc (SABS) — Free Cash Flow Generation Index
SAB Biotherapeutics Inc (SABS) has a Free Cash Flow Generation Index of 85.55x as of December 2022. Free cash flow of $18.54 Million represents 86% of operating cash flow ($216.72K). Read total liabilities of SAB Biotherapeutics Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SAB Biotherapeutics Inc Free Cash Flow Generation Index (2020–2021)
Historical FCF Generation Index trend for SAB Biotherapeutics Inc across 2 annual periods. Explore reinvestment intensity of SAB Biotherapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for SAB Biotherapeutics Inc (2020–2021)
Year-by-year Free Cash Flow Generation Index for SAB Biotherapeutics Inc. For the full company profile including market capitalisation, see SAB Biotherapeutics Inc stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | -4.51x | $-8.96 Million | $1.99 Million | $10.94 Million | ▼ -1553.9% |
| 2020 | -0.27x | $-2.73 Million | $10.00 Million | $12.73 Million | — |